XSHG603067
Market cap820mUSD
Jan 06, Last price
11.87CNY
1D
0.17%
1Q
-8.69%
Jan 2017
-17.97%
IPO
139.80%
Name
Hubei Zhenhua Chemical Co Ltd
Chart & Performance
Profile
Hubei Zhenhua Chemical Co.,Ltd. engages in the research, development, production, and marketing of chromium salt products in China. The company offers sodium bichromate and dichromate, chromic acid anhydride, crystal chromic acid anhydride, liquid chromic anhydride, chrome oxide green, chromic trioxide, potassium dichromate, basic chrome sulphate, vitamin K3, sodium sulphate anhydrous, aluminium hydroxide, etc. It also exports its products to Europe, the United States, Africa, and Southeast Asia. The company was formerly known as Huanghsi Zhenhua Chemical Industry Co., Ltd. Hubei Zhenhua Chemical Co.,Ltd. was founded in 1967 and is based in Huangshi, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 3,698,699 4.67% | 3,533,801 18.06% | |||||||
Cost of revenue | 3,188,717 | 2,845,255 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 509,982 | 688,545 | |||||||
NOPBT Margin | 13.79% | 19.48% | |||||||
Operating Taxes | 42,163 | 59,807 | |||||||
Tax Rate | 8.27% | 8.69% | |||||||
NOPAT | 467,819 | 628,739 | |||||||
Net income | 370,809 -11.07% | 416,973 34.22% | |||||||
Dividends | (136,876) | (93,549) | |||||||
Dividend yield | 2.64% | 1.43% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 113,676 | 556,948 | |||||||
Long-term debt | 653,262 | 333,946 | |||||||
Deferred revenue | 12,747 | 8,521 | |||||||
Other long-term liabilities | 12,772 | 34 | |||||||
Net debt | 363,874 | 467,197 | |||||||
Cash flow | |||||||||
Cash from operating activities | 396,314 | 490,979 | |||||||
CAPEX | (292,662) | ||||||||
Cash from investing activities | (274,208) | ||||||||
Cash from financing activities | |||||||||
FCF | 293,664 | 278,007 | |||||||
Balance | |||||||||
Cash | 271,132 | 310,501 | |||||||
Long term investments | 131,932 | 113,196 | |||||||
Excess cash | 218,129 | 247,007 | |||||||
Stockholders' equity | 2,079,002 | 1,944,381 | |||||||
Invested Capital | 3,429,035 | 3,196,962 | |||||||
ROIC | 14.12% | 21.09% | |||||||
ROCE | 13.71% | 19.61% | |||||||
EV | |||||||||
Common stock shares outstanding | 507,957 | 508,500 | |||||||
Price | 10.19 -20.58% | 12.83 16.21% | |||||||
Market cap | 5,176,082 -20.66% | 6,524,050 19.84% | |||||||
EV | 5,602,332 | 7,029,588 | |||||||
EBITDA | 705,058 | 877,386 | |||||||
EV/EBITDA | 7.95 | 8.01 | |||||||
Interest | 35,273 | 33,789 | |||||||
Interest/NOPBT | 6.92% | 4.91% |